Cannasouth Limited
Cannasouth Limited
Share · NZCBDE0009S6 (XNZE)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 99,18 %
Shares Float 327,77 M
Shares Outstanding 330,47 M
Company Profile for Cannasouth Limited Share
Cannasouth Limited, a biopharmaceutical company, engages in the research, development, manufacture, and supply of cannabinoid medicines and cannabis biomass in New Zealand. The company was incorporated in 2018 and is based in Hamilton, New Zealand.
Get up to date insights from finAgent about Cannasouth Limited

Company Data

Name Cannasouth Limited
Company Cannasouth Limited
Website https://www.cannasouth.co.nz
Primary Exchange XNZE NZX
ISIN NZCBDE0009S6
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mark John Lucas
Market Capitalization 32 Mio
Country New Zealand
Currency NZD
Employees 0,0 T
Address CRV Building, 3216 Hamilton
IPO Date 2019-06-18

Ticker Symbols

Name Symbol
NZX CBD.NZ
More Shares
Investors who hold Cannasouth Limited also have the following shares in their portfolio:
NGENIC AB
NGENIC AB Share
SP Funds S&P Global REIT Sharia ETF
SP Funds S&P Global REIT Sharia ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025